Cargando…
The impact of erlotinib use in non-small-cell lung cancer patients treated in a private reference general hospital and in a private cancer clinic from 2005 to 2011
OBJECTIVE: To report the demographic data and clinical outcomes of non-small-cell lung cancer patients exposed to erlotinib in any line of treatment. METHODS: This was a retrospective cohort study of nonsmall-cell lung cancer patients from a reference general hospital and a private oncology clinic,...
Autores principales: | Bognar, Cinthia Leite Frizzera Borges, Simon, Sergio Daniel, Gansl, Rene Claudio, Abramoff, Roberto, Aisen, Marcelo, Lopes, Gilberto de Lima, Smaletz, Oren, Peres, Stela Verzinhasse, Tabacof, Jacques |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto de Ensino e Pesquisa Albert Einstein
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943812/ https://www.ncbi.nlm.nih.gov/pubmed/26154542 http://dx.doi.org/10.1590/S1679-45082015AO3326 |
Ejemplares similares
-
Treatment of breast cancer patients from a public healthcare system in a private center: costs of care for a pilot public-private partnership in oncology
por: Kaliks, Rafael Aliosha, et al.
Publicado: (2013) -
Compulsory Licenses for Cancer Drugs: Does Circumventing Patent Rights Improve Access to Oncology Medications?
por: Bognar, Cinthia Leite Frizzera Borges, et al.
Publicado: (2016) -
Private health insurance coverage of drug use disorder treatment: 2005–2018
por: Mojtabai, Ramin, et al.
Publicado: (2020) -
Evaluation of pharmacy information system in teaching, private and social services Hospitals in 2011
por: Saghaeiannejad-Isfahani, Sakineh, et al.
Publicado: (2014) -
Private towers /
por: Trulove, James Grayson
Publicado: (2002)